血管性认知障碍的诊疗规范(2020 年版)

2020-09-30 中华人民共和国国家卫生健康委员会 全科医学临床与教育.2021.19(3):197-199.

以脑卒中为代表的脑血管性疾病,除引起运动、感觉、视觉和吞咽障碍外,还会导致焦虑、抑郁、情感失禁、淡漠、失眠、疲劳、意志力缺乏等人格行为改变,以及注意下降、反应迟钝、记忆下降、失语、执行功能减退等血管性

中文标题:

血管性认知障碍的诊疗规范(2020 年版)

发布日期:

2020-09-30

简要介绍:

以脑卒中为代表的脑血管性疾病,除引起运动、感觉、视觉和吞咽障碍外,还会导致焦虑、抑郁、情感失禁、淡漠、失眠、疲劳、意志力缺乏等人格行为改变,以及注意下降、反应迟钝、记忆下降、失语、执行功能减退等血管性认知障碍。血管性认知障碍可发生于任何年龄、任何类型脑血管疾病,但是老年人更加易感,且病因以卒中更加常见。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=血管性认知障碍的诊疗规范_2020年版_.pdf)] GetToolGuiderByIdResponse(projectId=1, id=3053f1c0020998ed, title=血管性认知障碍的诊疗规范(2020 年版), enTitle=, guiderFrom=全科医学临床与教育.2021.19(3):197-199., authorId=0, author=, summary=以脑卒中为代表的脑血管性疾病,除引起运动、感觉、视觉和吞咽障碍外,还会导致焦虑、抑郁、情感失禁、淡漠、失眠、疲劳、意志力缺乏等人格行为改变,以及注意下降、反应迟钝、记忆下降、失语、执行功能减退等血管性, cover=https://img.medsci.cn/2021517/1621267157024_2020535.png, journalId=0, articlesId=null, associationId=1653, associationName=中华人民共和国国家卫生健康委员会, associationIntro=, copyright=0, guiderPublishedTime=Wed Sep 30 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>以脑卒中为代表的脑血管性疾病,除引起运动、感觉、视觉和吞咽障碍外,还会导致焦虑、抑郁、情感失禁、淡漠、失眠、疲劳、意志力缺乏等人格行为改变,以及注意下降、反应迟钝、记忆下降、失语、执行功能减退等血管性认知障碍。血管性认知障碍可发生于任何年龄、任何类型脑血管疾病,但是老年人更加易感,且病因以卒中更加常见。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=37645, tagName=血管性认知障碍)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=37645, guiderKeyword=血管性认知障碍, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4215, appHits=398, showAppHits=0, pcHits=1363, showPcHits=3817, likes=3, shares=56, comments=13, approvalStatus=1, publishedTime=Tue May 18 00:22:12 CST 2021, publishedTimeString=2020-09-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Mon May 17 23:59:23 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 19:41:56 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=血管性认知障碍的诊疗规范_2020年版_.pdf)])
血管性认知障碍的诊疗规范_2020年版_.pdf
下载请点击:
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2094368, encodeId=2f2a209436808, content=规范指导临床, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210323/9e19622684d0495ab64e9c2d9662c072/5dbfd70bbbc341839babfa759db3f40b.jpg, createdBy=d8d72465758, createdName=12428a36m61暂无昵称, createdTime=Tue Oct 18 09:56:40 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076296, encodeId=e14d10e629670, content=值得关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85ed5259629, createdName=壹生-追上那个被寄予厚望的自己, createdTime=Thu Dec 02 18:52:05 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005257, encodeId=8a4b100525e26, content=值得关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211109/8ac3a71b1b614fd4864d9f8a3b944ae1/774ac5affc1b45f6b793bdf5644aeaef.jpg, createdBy=16434740929, createdName=hydlixuling, createdTime=Thu Aug 05 06:25:59 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996097, encodeId=009499609e27, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=309a5540954, createdName=ms8000001833679170, createdTime=Sun Jul 04 14:02:00 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977873, encodeId=65359e7873b1, content=好共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22e25391263, createdName=ms7000001379254810, createdTime=Tue Jun 29 11:29:30 CST 2021, time=2021-06-29, status=1, ipAttribution=)]
    2022-10-18 12428a36m61暂无昵称

    规范指导临床

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2094368, encodeId=2f2a209436808, content=规范指导临床, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210323/9e19622684d0495ab64e9c2d9662c072/5dbfd70bbbc341839babfa759db3f40b.jpg, createdBy=d8d72465758, createdName=12428a36m61暂无昵称, createdTime=Tue Oct 18 09:56:40 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076296, encodeId=e14d10e629670, content=值得关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85ed5259629, createdName=壹生-追上那个被寄予厚望的自己, createdTime=Thu Dec 02 18:52:05 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005257, encodeId=8a4b100525e26, content=值得关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211109/8ac3a71b1b614fd4864d9f8a3b944ae1/774ac5affc1b45f6b793bdf5644aeaef.jpg, createdBy=16434740929, createdName=hydlixuling, createdTime=Thu Aug 05 06:25:59 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996097, encodeId=009499609e27, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=309a5540954, createdName=ms8000001833679170, createdTime=Sun Jul 04 14:02:00 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977873, encodeId=65359e7873b1, content=好共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22e25391263, createdName=ms7000001379254810, createdTime=Tue Jun 29 11:29:30 CST 2021, time=2021-06-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2094368, encodeId=2f2a209436808, content=规范指导临床, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210323/9e19622684d0495ab64e9c2d9662c072/5dbfd70bbbc341839babfa759db3f40b.jpg, createdBy=d8d72465758, createdName=12428a36m61暂无昵称, createdTime=Tue Oct 18 09:56:40 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076296, encodeId=e14d10e629670, content=值得关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85ed5259629, createdName=壹生-追上那个被寄予厚望的自己, createdTime=Thu Dec 02 18:52:05 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005257, encodeId=8a4b100525e26, content=值得关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211109/8ac3a71b1b614fd4864d9f8a3b944ae1/774ac5affc1b45f6b793bdf5644aeaef.jpg, createdBy=16434740929, createdName=hydlixuling, createdTime=Thu Aug 05 06:25:59 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996097, encodeId=009499609e27, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=309a5540954, createdName=ms8000001833679170, createdTime=Sun Jul 04 14:02:00 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977873, encodeId=65359e7873b1, content=好共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22e25391263, createdName=ms7000001379254810, createdTime=Tue Jun 29 11:29:30 CST 2021, time=2021-06-29, status=1, ipAttribution=)]
    2021-08-05 hydlixuling

    值得关注

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2094368, encodeId=2f2a209436808, content=规范指导临床, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210323/9e19622684d0495ab64e9c2d9662c072/5dbfd70bbbc341839babfa759db3f40b.jpg, createdBy=d8d72465758, createdName=12428a36m61暂无昵称, createdTime=Tue Oct 18 09:56:40 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076296, encodeId=e14d10e629670, content=值得关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85ed5259629, createdName=壹生-追上那个被寄予厚望的自己, createdTime=Thu Dec 02 18:52:05 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005257, encodeId=8a4b100525e26, content=值得关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211109/8ac3a71b1b614fd4864d9f8a3b944ae1/774ac5affc1b45f6b793bdf5644aeaef.jpg, createdBy=16434740929, createdName=hydlixuling, createdTime=Thu Aug 05 06:25:59 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996097, encodeId=009499609e27, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=309a5540954, createdName=ms8000001833679170, createdTime=Sun Jul 04 14:02:00 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977873, encodeId=65359e7873b1, content=好共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22e25391263, createdName=ms7000001379254810, createdTime=Tue Jun 29 11:29:30 CST 2021, time=2021-06-29, status=1, ipAttribution=)]
    2021-07-04 ms8000001833679170

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2094368, encodeId=2f2a209436808, content=规范指导临床, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210323/9e19622684d0495ab64e9c2d9662c072/5dbfd70bbbc341839babfa759db3f40b.jpg, createdBy=d8d72465758, createdName=12428a36m61暂无昵称, createdTime=Tue Oct 18 09:56:40 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076296, encodeId=e14d10e629670, content=值得关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85ed5259629, createdName=壹生-追上那个被寄予厚望的自己, createdTime=Thu Dec 02 18:52:05 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005257, encodeId=8a4b100525e26, content=值得关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211109/8ac3a71b1b614fd4864d9f8a3b944ae1/774ac5affc1b45f6b793bdf5644aeaef.jpg, createdBy=16434740929, createdName=hydlixuling, createdTime=Thu Aug 05 06:25:59 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996097, encodeId=009499609e27, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=309a5540954, createdName=ms8000001833679170, createdTime=Sun Jul 04 14:02:00 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977873, encodeId=65359e7873b1, content=好共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22e25391263, createdName=ms7000001379254810, createdTime=Tue Jun 29 11:29:30 CST 2021, time=2021-06-29, status=1, ipAttribution=)]
    2021-06-29 ms7000001379254810

    好共识

    0